<DOC>
	<DOCNO>NCT01916993</DOCNO>
	<brief_summary>The purpose research study : test safety , tolerability , pharmacokinetics ( PK testing , study body absorbs , distributes , break eliminate drug ) single dose investigational study drug NBI-98854 subject normal hepatic function mild , moderate , severe hepatic impairment .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Single Dose NBI-98854 Subjects With Mild , Moderate , Severe Hepatic Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<criteria>Male female , 18 75 year age . Healthy volunteer must good general health . Subjects hepatic impairment must judge stable condition . Subjects childbearing potential must agree use hormonal two form nonhormonal birth control study . Female subject must pregnant , give birth within 1 year study start , breastfeed . Have body mass index ( BMI ) 18 40 kg/m2 ( inclusive ) . Report two alcoholic beverage daily 14 alcoholic beverage weekly withing 7 day study start . Have know history neuroleptic malignant syndrome . Have positive human immunodeficiency virus ( HIV ) antibody result screen history positive result . Have receive investigational drug within 30 day screen plan use investigational drug ( NBI98854 ) study . Have allergy , hypersensitivity , intolerance tetrabenazine . Had blood loss great equal 500 mL donate blood within 56 day study start . Have previous exposure NBI98854 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>